PCI offers a global network of in-house analytical testing capabilities with laboratories located in North America, Europe, the UK and Asia Pacific, delivering analytical services from the earliest stages of pharmaceutical development through to commercialization, supporting manufacturing, packaging, release and distribution for global supply.
Our analytical services support a wide range of product types including:
- High potency
- High toxicity
- Controlled drugs schedule I-V
- Solid, semi-solid and liquid dosage forms
- Biologic drug products
- Medical devices and other drug delivery systems
- Respiratory and inhaler systems
Analytical services include:- Method transfer
- Method development
- Method validation
- UPLC method testing
- Cleaning verification
- Cleaning validation
- Raw materials testing
- Importation testing
- EU release testing
- Finished product testing
- Routine testing
- Mass spectrometry identification
- ICH stability storage and testing
- Pharmacopeia testing (USP/NF, EP, BP)
- Comparator product testing
- Clinical and commercial packaging support testing
- Micro testing
Stability storage available conditions:- 50C
- 250C/60%RH
- 300C/65%RH
- 300C/75%RH
- 400C/75%RH
- -200C
As an integrated, global CDMO, our in-house analytical testing capabilities provide end-to-end solutions from development to commercialization.